Actively Recruiting
The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement
Led by Ajou University School of Medicine · Updated on 2025-10-03
96
Participants Needed
1
Research Sites
174 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Maxigesic is combined intravenous analgesic of ibuprofen and acetaminphen. The purpose of this study is investigate weather preoperative Maxigesic administration can reduce intraoperative remifentanil requirement.
CONDITIONS
Official Title
The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 19 to 60 years
- ASA physical status 1, 2, or 3
- Scheduled for surgery under general anesthesia
You will not qualify if you...
- Patient does not consent
- Pregnancy
- Liver (hepatic) disorder
- Kidney (renal) disorder
- Asthma
- Allergic reaction to NSAIDs or acetaminophen
- Receiving chronic pain therapy
- Drug dependence
- Taking psychiatric medications
- Alcoholism
- History of gastrointestinal ulcer or bleeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ajou university school of medicine
Suwon, Gyeonggi-do, South Korea, 16499
Actively Recruiting
Research Team
I
In Kyong Yi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here